UPDATE: Morgan Stanley Upgrades Forest Laboratories Ahead of Further Financial Upside

In a report published Tuesday, Morgan Stanley analyst David Risinger upgraded the rating on Forest Laboratories (NYSE: FRX ) from Equal-Weight to Overweight, and named an $86.00 price target. In the report, Morgan Stanley noted, “Our Base Case is an earnings and multiple call: cons under-estimates durability of growth. We